Stem cell plasticity: Clinical implications

Experimental Hematology

Volumn 36, Issue 6, 2008, Pages 669-671

  Quesenberry, Peter J ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

BONE MARROW TRANSPLANTATION; CELL CULTURE; CELL THERAPY; CHRONIC DISEASE; CLINICAL STUDY; CLINICAL TRIAL; DIABETES MELLITUS; EDITORIAL; ENDOTHELIUM CELL; HEART DISEASE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA CELL; LIVER DISEASE; MESENCHYME CELL; MONONUCLEAR CELL; PERIPHERAL VEIN; PHENOTYPIC VARIATION; PLASTICITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

BONE MARROW TRANSPLANTATION; CLINICAL TRIALS AS TOPIC; EMBRYONIC STEM CELLS; HUMANS; LIVER DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STEM CELL TRANSPLANTATION;

EID: 43049164297     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2008.01.016     Document Type: Editorial

References (18)

1. Charwat S., Gyongyosi M., Lang I., et al. Role of adult bone marrow stem cells in the repair of ischemic myocardium-current state of the art. Exp Hematol 36 (2008) 672-680
2. Kastrup J., and Ripa R. G-CSF therapy with mobilization of bone marrow stem cells for myocardial recovery after acute myocardial infarction-a relevant treatment?. Exp Hematol 36 (2008) 681-686
3. Haller M.J., Viener H.L., Wasserfall C., Brusko T., Atkinson M.A., and Schatz D.A. Autologous umbilical cord blood infusion for type 1 diabetes. Exp Hematol 36 (2008) 710-715
4. Brunner S., Huber B.C., Fischer R., et al. G-CSF treatment after myocardial infarction-impact on bone marrow-derived versus cardiac progenitor cells. Exp Hematol 36 (2008) 695-702
5. Gordon M.Y. Stem cells for regenerative medicine-biological attributes and clinical application. Exp Hematol 36 (2008) 726-732
6. Engelmann M.G., Theiss H.D., Theiss C., et al. G-CSF in patients suffering from late revascularized ST elevation myocardial infarction: analysis on the timing of G-CSF administration. Exp Hematol 36 (2008) 703-709
7. Jones B.J., and McTaggart S. Immunosuppression by mesenchymal stromal cells: from culture to clinic. Exp Hematol 36 (2008) 733-741
8. Cogle C.R., Madlambayan G.J., Hubsher G., et al. Marrow cell therapies for cardiovascular diseases. Exp Hematol 36 (2008) 687-694
9. Ellor S., Shupe T., and Petersen B. Stem cell therapy for inherited metabolic disorders of the liver. Exp Hematol 36 (2008) 716-725
10. Quesenberry PJ, Dooner G, Dooner M, Abedi M. Developmental biology: Ignoratio Elenchi: red herrings in stem cell research. Science. 3005;308:1121.
11. Jiang Y., Jahagirdar B.N., Reinhardt R.L., et al. Pluripotency of mesenchymal stem cells derived from adult bone marrow. Nature 418 (2002) 41-49
12. Kogler G., Sensken S., Airey J.A., et al. A new somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 200 (2004) 123-135
13. D'Ippolito G., Howard G.A., Roos B.A., and Schiller P.C. Isolation and characterization of marrow isolated multilineage inducible (MIAMI) cells. Exp Hematol 34 (2006) 1608-1610
14. Pochampally R.R., Smith J.R., Ylotalo J., and Prockop D.J. Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanced expression of OCT-4 and other embryonic genes. Blood 103 (2004) 1647-1652
15. Kucia M., Zhang Y.P., Campbell F., et al. A population of very small embryonic-like (VSEL) CXCR4 (+), SSEA (+), Oct-4+ stem cells identified in adult bone marrow. Leukemia 20 (2006) 857-869
16. Ratajczak J., Miekus K., Kucia M., et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors; evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20 (2006) 847-856
17. Aliotta J.M., Sanchez-Guijo F.M., Dooner G.J., et al. Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation. Stem Cells 25 (2007) 2245-2256
18. Deregibus M.C., Cantaluppi V., Calogero R., et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 110 (2007) 2440-2448